Medically Verified Protocol

Kquality-assured &

Formulation Data

Active Ingredient: Clostridium Botulinum Toxin Type A (200 Units/).

Stabilizer: 0.9mg Sodium Chloride (NaCl).

Appearance: White or light yellow lyophilized powder in a sterile, transparent glass.

Shelf Life: 36 months from manufacturing date under strict refrigeration protocols.

Strictly restricted to licensed medical practitioners. Administration requires thorough anatomical knowledge of facial musculature.

Contraindications: Do not administer to individuals with known hypersensitivity to botulinum toxin type A or human serum albumin. Contraindicated in patients with neuromuscular junction disorders (e.g., Myasthenia Gravis, Amyotrophic Lateral Sclerosis) and during pregnancy or lactation.

Adverse Reactions: Potential localized side effects include ecchymosis, injection site erythema, and transient headache. Distant spread of toxin effect causing ptosis or dysphagia occurs rarely but requires immediate clinical intervention.